Gene · 2829
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Will Omics Biotechnologies Save Us from Future Pandemics? Lessons from COVID-19 for Vaccinomics and Adversomics. | Biomedicines | 2022 | 36672560 | PubTator, text mining | PubMed |
| Immunogenetic Predisposition to SARS-CoV-2 Infection. | Biology (Basel) | 2022 | 36671730 | PubTator, text mining | PubMed |
| Skin-homing basophils and beyond. | Front Immunol | 2022 | 36618424 | PubTator, text mining | PubMed |
| Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients. | Cancers (Basel) | 2022 | 36612166 | PubTator, text mining | PubMed |
| Immune activation of characteristic gut mycobiota Kazachstania pintolopesii on IL-23/IL-17R signaling in ankylosing spondylitis. | Front Cell Infect Microbiol | 2022 | 36605130 | PubTator, text mining | PubMed |
| Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy. | Vaccines (Basel) | 2022 | 36560459 | PubTator, text mining | PubMed |
| Natural Polyphenols for Treatment of Colorectal Cancer. | Molecules | 2022 | 36557939 | PubTator, text mining | PubMed |
| CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy. | Int J Mol Sci | 2022 | 36555280 | PubTator, text mining | PubMed |
| Comprehensive Analysis of FASN in Tumor Immune Infiltration and Prognostic Value for Immunotherapy and Promoter DNA Methylation. | Int J Mol Sci | 2022 | 36555243 | PubTator, text mining | PubMed |
| The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network. | Cancers (Basel) | 2022 | 36551635 | PubTator, text mining | PubMed |
| Plant-Derived Bioactive Compounds and Potential Health Benefits: Involvement of the Gut Microbiota and Its Metabolic Activity. | Biomolecules | 2022 | 36551299 | PubTator, text mining | PubMed |
| Parallel single-cell and bulk transcriptome analyses reveal key features of the gastric tumor microenvironment. | Genome Biol | 2022 | 36550535 | PubTator, text mining | PubMed |
| Meningeal lymphatic drainage promotes T cell responses against Toxoplasma gondii but is dispensable for parasite control in the brain. | Elife | 2022 | 36541708 | PubTator, text mining | PubMed |
| Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and Naturally Occurring Compounds, Part II. | Ann Clin Case Rep | 2022 | 36540866 | PubTator, text mining | PubMed |
| Immunity Cell Responses to RSV and the Role of Antiviral Inhibitors: A Systematic Review. | Infect Drug Resist | 2022 | 36540102 | PubTator, text mining | PubMed |
| Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model. | Sci Rep | 2022 | 36513720 | PubTator, text mining | PubMed |
| Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis. | J Neuroinflammation | 2022 | 36510261 | PubTator, text mining | PubMed |
| Cell atlas of the immune microenvironment in gastrointestinal cancers: Dendritic cells and beyond. | Front Immunol | 2022 | 36505406 | PubTator, text mining | PubMed |
| Single-Cell Sequencing in Rheumatic Diseases: New Insights from the Perspective of the Cell Type. | Aging Dis | 2022 | 36465169 | PubTator, text mining | PubMed |
| The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells. | iScience | 2022 | 36437872 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2829/papers?page=19